D.N.D.I. offers alternative patents
20 July 2017
In the States parties are worried that new medication, which is been partly developed by public research, is offered for steep prices by farmaceutical industrie. But there is hope. The New York Times writes on a company that chooses an alternative strategy, Drugs for Neglected Disease Initiative (D.N.D.I) is founded by doctor Bernard Pécoul, who worked for Doctors Without Borders.
Read more in the NYT